Albany Molecular Research (AMRI) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/7/2026
- US stocks gain as surprise payrolls fall quells rate-hike fears
- US nonfarm payrolls unexpectedly decline in July; unemployment rate eases to 4.1%
- Oil prices drop as investors weigh potential Hormuz deal between Iran and Gulf states
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Trump held multiple undisclosed calls with Fed Chair Warsh, reports say
- Stocks close lower as investors eye Mideast talks, earnings
- Apollo to acquire easyJet for £5.7B in cash deal
- The Trade Desk Inc. (TTD) Tops Q2 EPS by 16c, Misses on Revenue; Offers Weak Q3 Revenue Guidance
- Nielsen to acquire DoubleVerify in merger deal
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
AMRI Announces Second Quarter 2015 Results
August 4, 2015 7:30 AM EDTALBANY, N.Y., Aug. 4, 2015 /PRNewswire/ --Â AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2015.
Highlights:
Second quarter contract revenue of $85.2 million, a 39% increase from 2014 Adjusted contract margins of 26% Second quarter adjusted diluted EPS of $0.22, including a $0.05 decrease in EPS from royalties in the current quarter Operating cash flow of $16 million"We are very pleased to present another strong financial quarter, with all our divisions achieving excellent... More
